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Inclusion bodies puriﬁcationa b s t r a c t
Inclusion bodies (IBs) are commonly formed in Escherichia coli due to over expression of recombinant pro-
teins in non-native state. Isolation, denaturation and refolding of these IBs is generally performed to
obtain functional protein. However, during this process IBs tend to form non-speciﬁc interactions with
sheared nucleic acids from the genome, thus getting carried over into downstream processes. This may
hinder the refolding of IBs into their native state. To circumvent this, we demonstrate a methodology
termed soni-removal which involves disruption of nucleic acid–inclusion body interaction using sonica-
tion; followed by solvent based separation. As opposed to conventional techniques that use enzymes and
column-based separations, soni-removal is a cost effective alternative for complete elimination of buried
and/or strongly bound short nucleic acid contaminants from IBs.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Inclusion bodies (IBs) are cellular insoluble aggregates that are
commonly formed during over expression of heterologous proteins
in Escherichia coli. This occurs mainly due to the formation of par-
tially folded aggregates in the cytoplasm of E. coli, where post-
translational modiﬁcations are absent [1]. To obtain soluble pro-
tein, these inclusion bodies are processed by a series of steps like
cell lysis, denaturation and refolding in vitro. However, many
instances show that, IBs can form complexes with contaminants
like lipids, nucleic acids and other proteins along the process [1].
The elimination of such contamination is inevitable for protein–
nucleic acid interaction studies and therapeutic applications [2–4].
During cell lysis endogenous nucleic acids may get sheared
resulting in shorter to longer fragments. These sheared nucleic
acids interact differently forming weak to stronger non-speciﬁc
interactions with IBs depending on their afﬁnity. Moreover, with
steps that follow like denaturation and refolding, IBs and nucleic
acids in soluble state are more susceptible to form complexes as
the contamination is carried over. Thus, nucleic acids are the major
contaminants during the expression of recombinant proteins as IBs
[5]. To remove nucleic acids from IBs, mechanical, chemical and
enzymatic techniques are commonly employed. However, the pro-
cedures used for such applications results in loss of sample as theyrequire multiple steps to remove nucleic acids [6–8]. Enzymatic
methods should be avoided as downstream applications maybe
hindered; for example, the use of nucleases should be avoided
for protein–nucleic acid interaction studies, selection of aptamers
for a speciﬁc protein target, etc. Also, in many cases, enzymes like
benzonases fail to completely remove nucleic acids from com-
plexes due to inaccessibility of shorter nucleic acids buried in the
refolded protein as demonstrated in this study. The failure of con-
ventional techniques in eliminating nucleic acid contamination
creates a need for the development of more effective yet simple
methodologies.
It is a common practice to solubilize IBs using chemical dena-
turants like Urea, Guanidine-HCl and Lauryl glutamate before
refolding them. However, these denaturants would solubilize both
IBs and nucleic acids, thus making them inseparable [1]. Thus, by
maintaining IBs in their insoluble state and nucleic acids in solu-
tion; appropriate aqueous buffers would allow separation by
high-speed centrifugation. This scenario can be simulated prior
to the denaturation step. However, conventional methods do not
target this critical step, thus could result in carryover of contami-
nation [6–8].
Soni-removal aids in disruption of interaction between IBs and
nucleic acids by simple sonication steps without the use of
enzymes or chromatographic procedures. Sonication breaks the
weak ionic, hydrogen and hydrophobic interactions but not the
covalent peptide bonds therefore leaving IBs unaffected [6]. Inter-
estingly, as the interaction between nucleic acid contaminants and
IBs are not covalent in nature, we identiﬁed sonication as a key
technique in achieving the above objectives prior to denaturation
Fig. 1. Schematic representation for the removal of nucleic acid contaminants from IBs.
Fig. 2. Determination of nucleic acid contamination in puriﬁed protein: (A) CD44 was refolded and monomeric proteins were separated by gel ﬁltration on Superdex-75. The
fractions were collected and run on a 12% Native PAGE. (B) UV analysis shows sheared nucleic acid contaminants strongly bound or buried in the refolded proteins of CD44-
HABD and DENV2-EDIII.
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Fig. 3. Removal of nucleic acid contaminants: SYBR green stained NuPAGE 3–8% Tris–Acetate gel showing removal of nucleic acid contamination by sonication treatment for
CD44HABD (A) and DENV2-EDIII (B), respectively. Lane M – exATCgene Low range DNA marker (Fisher Scientiﬁc). Lanes 1 and 2 – Insoluble pellet from cell lysate in PBS
showing nucleic acid contamination before and after sonication treatment, respectively. Lane 3 – Supernatant from centrifugation after sonication treatment showing
presence of nucleic acids in PBS. Lane 4 – Absence of nucleic acid contamination in the pellet containing the protein, resuspended in denaturing buffer. (C) The UV scans of
CD44-HABD (1) and DENV2-EDIII (1), represents the diluted supernatants of CD44-HABD (10 times) and DENV2-EDIII (2 times) that were obtained from the ﬁrst spin
(16,000g) and the scans of CD44-HABD (2) and DENV2-EDIII (2) represents the supernatants of undiluted samples after the second spin (16,000g). (D) UV scan showing for the
protein sample free of nucleic acids after the sonication treatment. The pellet was resuspended (after centrifugation 16,000g) in the denaturing buffer (8 M Urea, 50 mMMES
pH 6.5, 0.1 mM EDTA).
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denaturation step in aqueous buffer, insoluble IBs are easily sepa-
rated by high-speed centrifugation as mentioned earlier. This son-
ication has a different effect as compared to the one applied during
cell lysis, which disrupts the cell wall and shears endogenous
nucleic acids. Here, we demonstrate soni-removal for two proteins,
namely CD44-Hyaluronan binding domain (CD44-HABD) and Den-
gue Virus type-2 envelope domain III (DENV2-EDIII). Of which,
both IBs display nucleic acid contamination after refolding by using
conventional puriﬁcation steps including benzonase treatment.
After demonstrating the failure of conventional methods, we eluci-
date how the application of soni-removal at the critical step can
fulﬁll the need for complete elimination of nucleic acid contami-
nants from IBs.2. Material and methods
2.1. Expression of IBs of CD44-HABD and DENV-2 EDIII
Human CD44 DNA construct coding 20–178 of the ﬁnal residue
after the signal sequence and ﬁrst 158 residues from the N-termi-
nus of the mature protein was synthesized from GeneScript with
NcoI and BglII sites for ligation into the expression vector pET19b
(Novagen). The DENV2-EDIII protein was expressed in CR2566
strain of E. coli containing a plasmid encoding for DENV2-EDIII.
The protein expression was checked on SDS–PAGE. The previously
published protocol for puriﬁcation of Flavivirus ED3s was followed
[9,10].
In case of both proteins, cells were lysed by sonication. Where,
both samples were subjected to 6 cycles of 30 s ON and OFF at 50%
power (Misonix sonicator) until the pellets were homogeneous.
The sonicated cells were centrifuged at 4 C for 1 h at 10000 rpm
to pellet the IBs. For DENV2-EDIII, the supernatant was discarded
and pellet was resuspended in 40 ml denaturing buffer [20 mMTris–HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 6 M Guanidine HCl
and 5% (v/v) glycerol] using a rotating mixer or slow rocking at
4 C for about 12–24 h until pellet is homogenous. The resus-
pended solution was centrifuged at 8000 rpm for 1 h (at 4 C) to
pellet the insoluble fraction and the supernatant contains the
denatured IBs. CD44-HABD protein was expressed as IBs and puri-
ﬁed as described by Banerji et al. [11].2.2. Puriﬁcation of IBs of DENV-2 EDIII and CD44-HABD
DENV-2 EDIII and CD44-HABD were puriﬁed as described by
Volk et al. [9,10] and Banerji et al. [11], respectively. In case of
DENV-2EDIII, the dialyzed protein was passed through 30 kDa
cut-off in Amicon Ultra centrifugal ﬁlters (15 ml volume – from
Millipore) for removing higher molecular weight protein and
nucleic acid contaminants that might have co-eluted with protein
(checked for nucleic acid contamination using UV-spec 260/280
ratio). The protein was then concentrated and buffer exchanged,
using 3 kDa cut-off in Amicon Ultra centrifugal ﬁlters (Millipore)
and purity was conﬁrmed by UV scan.2.3. Sonication treatment for nucleic acid removal
IBs of both proteins obtained from 1 L culture were processed as
described earlier, resuspended in the 30 ml phosphate buffer saline
(1  PBS) and homogenized. A portion (15 ml) of the pellet was
centrifuged and supernatant was discarded. The pellet was resus-
pended in denaturing buffer (8 M Urea containing 50 mM MES
(pH6.5), 0.1 mM EDTA and 0.1 mM DTT) for gel electrophoresis
and UV scan.
The second portion of both pellets was employed for sonication
treatment. The sonication treatment was performed for 2–10
cycles of 30 s pulse with 30 s interval on ice. Further, the treated
samples were centrifuged for 10 min at 16,000g. A small aliquot
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for conﬁrming the presence or absence of the nucleic acids
contamination.
2.4. Detecting nucleic acid contamination on PAGE
Presence or absence of nucleic acid contamination in both IBs
was checked by loading 10 ll on PAGE (NuPAGE 3–8% Tris–ace-
tate). The PAGE gel was further subjected to SYBR Green staining
(Molecular Probes, OR, USA) and observed at OD260.
3. Results and discussion
3.1. Detection of nucleic acid contamination in refolded protein
CD44-HABD and DENV2-EDIII IBs were expressed to validate
our strategy (Fig. 1). Soluble CD44-HABD IBs were obtained by
cytoplasmic expression as three intra-molecular sulﬁde bonds
are required to bring it to soluble form [11,12]. On the other hand,
DENV2-EDIII inclusion bodies were generated by expression
at 37 C [13]. Next, the cells were lysed by sonication andFig. 4. Optimization of sonication cycles for optimal disruption and SDS–PAGE: (A) 3–8%
acid contaminants removed by the sonication procedure at each cycle (0, 2, 6, 8, 10 rep
analysis data generated by FlurochemQ, a graph of intensity against number of sonicat
target protein occurred between 8 and 10 sonication cycles. (C) CD44-HABD and (D) DEN
pellet from cell lysate containing intact protein in PBS before and after sonication treatm
after sonication treatment, respectively; Lane 5 – Pellet after sonication treatment in decentrifugation was employed to isolate the IBs. The IBs being insol-
uble were easily separated and refolded in vitro. However, after
puriﬁcation, UV scan showed nucleic acid contamination in both
refolded proteins (Fig. 2A and B). Even after repeated washing, cen-
trifugation, denaturing and gel-permeation, the contamination was
prevalent. We also treated the refolded monomeric CD44-HABD
protein (Fig. 2A) with benzonase that cleaves both DNA and RNA.
However, it did not prove to be effective. We propose that this
maybe due to short nucleic acids getting buried inside
the protein molecule or strongly bound to the IBs at the
denaturation–refolding step.
3.2. Sonication treatment for removal of nucleic acid contaminants
Conventional techniques fail to completely remove nucleic acid
contaminants in case of refolded proteins; such contamination
could be carried over from the denaturation–refolding step. To
overcome this problem, we employed sonication prior to denatur-
ation for breaking the weak ionic, hydrogen and hydrophobic inter-
actions between IBs and nucleic acid contaminants. Here, both IBs
were prepared as described in the materials and methods sectionTris–acetate gel with SYBR green stain was run to determine the amount of nucleic
resents the number of sonication cycles, M is the marker). (B) Using densitometric
ion cycles was plotted. Maximum removal of nucleic acid contamination from the
V2-EDIII were run on SDS–PAGE, Lane M – Protein marker; Lanes 1 and 2 – Insoluble
ent, respectively; Lanes 3 and 4 – Supernatant from ﬁrst and second centrifugation
naturing buffer showing presence of intact protein.
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and B, lane 1). To break the interaction and release nucleic acids
from IBs, optimization by varying the number of sonication cycles
was carried out. This optimization was performed upto10 cycles
(i.e. 30 s pulse with 30 s intervals each) for both IBs containing
nucleic contamination (Fig. 4A and B). The number of cycles at
which maximum contamination is eliminated (10 cycles) was
applied for both IBs and the sonicated sample was centrifuged.
As insoluble IBs were present in aqueous buffer, they could be pel-
leted down easily as opposed to nucleic acids. The presence of
nucleic acids in the supernatant (Fig. 3A, see lane 3 and B, see lane
3) of both IBs (CD44-HABD (OD260 nm 20) and DENV2-EDIII
(OD260 nm 0.8)) indicated that nucleic acids were successfully
separated by sonication. We suspected that one sonication treat-
ment would not be sufﬁcient to eliminate strongly bound nucleic
acids as trace amounts of contamination may be present. There-
fore, the above sample was again resuspended in PBS and a second
sonication treatment (10 cycles) was employed. As nucleic acid
contaminants were observed in the ﬁrst sonication step, an identi-
cal second sonication was performed. After the second sonication
treatment, UV scan at OD 260 nm showed the release of some
nucleic acid in supernatant of both IBs (Fig. 3C). This highlights
the probable importance of the second sonication treatment to
release nucleic acid contaminants (Fig. 3C). A third sonication
was not applied as no more nucleic acid contamination was
detected by both UV scan and PAGE (Fig. 3A, B and D, lanes 4). This
additional sonication step varies from IB to IB; hence optimization
will have to be carried out for each IB of interest. Absence of
nucleic acid contaminants shows that this methodology is effec-
tive. Even the short nucleic acid fragments (less than 50 bp)
observed in the CD44-HABD IBs (Fig. 3A and B, lanes 2) were elim-
inated by our methodology. We propose that repeated sonication
cycles cause shearing and release of nucleic acids whereas; the
IBs remain unaffected (Fig. 4C and D). The use of our methodology
with minimal steps for complete removal of nucleic acids at the
critical step was successful.
The conventional procedures involving multiple steps to
remove nucleic acid contamination can be time consuming, costly
and less effective. Also, with increase in the number of steps
involved, there will be sample loss at each step during the process
as discussed earlier. However, our technique is simple, employs
minimal steps and therefore avoids the loss of sample. The unique
feature of our methodology lies in the separation of short nucleic
acid fragments that might be trapped in the protein during refold-
ing. As seen in case of CD44-HABD, such contamination cannot be
removed by using benzonase because of two reasons, (1) either the
benzonase cannot access the contaminants as they may be buried
inside the IB or (2) the cleavage of nucleic acids could lead to
shorter fragments that get rebound to the IB [14]. As such contam-
inants were successfully eliminated using our methodology, soni-
removal is more advantageous being employed at the critical step
resulting in complete elimination of nucleic acid contamination
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